114 related articles for article (PubMed ID: 2744187)
21. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
22. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
Sudik R; Fliess FR; Kunkel S
Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
[TBL] [Abstract][Full Text] [Related]
23. Prolactin changes in maternal plasma following termination by vacuum curettage and the effect of bromocriptine treatment on these changes.
Ylikorkala O; Rönnberg L
Br J Obstet Gynaecol; 1980 Oct; 87(10):911-5. PubMed ID: 7426491
[TBL] [Abstract][Full Text] [Related]
24. Bromocriptine therapy of luteal insufficiency accompanied with hyperprolactinemia in the follicular phase.
Kano T; Nishikawa K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):975-80. PubMed ID: 6875348
[TBL] [Abstract][Full Text] [Related]
25. Regulation of infant and developing rat testicular gonadotropin and prolactin receptors and steroidogenesis by treatments with human chorionic gonadotropin, gonadotropin-releasing hormone analogs, bromocriptine, prolactin, and estrogen.
Huhtaniemi IT; Warren DW; Catt KJ
Biol Reprod; 1985 May; 32(4):721-32. PubMed ID: 2988657
[TBL] [Abstract][Full Text] [Related]
26. Plasma hormones in clomiphene citrate therapy.
Wu CH
Obstet Gynecol; 1977 Apr; 49(4):443-8. PubMed ID: 857209
[TBL] [Abstract][Full Text] [Related]
27. [The therapeutic effect of parlodel in the polycystic ovary syndrome].
Soboleva EL; Komarov EK; Potin VV; Svechnikova FA
Akush Ginekol (Mosk); 1990 Sep; (9):61-3. PubMed ID: 2278313
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
29. [Effect of bromocriptine on the endocrine profile during pregnancy].
Kubota T; Yaoi Y; Suzuki A; Nishi N; Saito M; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1675-83. PubMed ID: 7175275
[TBL] [Abstract][Full Text] [Related]
30. [Effect of serum prolactin on cycle stimulation and fertilization of human oocytes].
Reinthaller A; Deutinger J; Csaicsich P; Riss P; Müller-Tyl E; Fischl F; Janisch H
Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):246-8. PubMed ID: 3109998
[TBL] [Abstract][Full Text] [Related]
31. Sex hormone changes underlying menstrual disturbances on haemodialysis.
Wass VJ; Wass JA; Rees L; Edwards CR; Ogg CS
Proc Eur Dial Transplant Assoc; 1978; 15():178-86. PubMed ID: 368772
[TBL] [Abstract][Full Text] [Related]
32. Transient hyperprolactinemia during cycle stimulation: influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment.
Reinthaller A; Bieglmayer C; Deutinger J; Csaicsich P
Fertil Steril; 1988 Mar; 49(3):432-6. PubMed ID: 3342894
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of a gonadotropin-releasing hormone agonist on the luteal synthesis of progesterone, estradiol receptors, and prolactin surges during early pregnancy.
Sridaran R; Ghose M; Mahesh VB
Endocrinology; 1988 Oct; 123(4):1740-6. PubMed ID: 3046924
[TBL] [Abstract][Full Text] [Related]
34. Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine.
Glazener CM; Kelly NJ; Hull MG
Gynecol Endocrinol; 1987 Dec; 1(4):373-8. PubMed ID: 3140587
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
36. [Estradiol, progesterone, gonadotropic hormone, chorionic gonadotropin and prolactin levels in women treated with clomiphene before and in the early stages of pregnancy].
Savchenko ON; Khrustaleva GF; Beskrovnaia NI
Akush Ginekol (Mosk); 1981 Jun; (6):21-4. PubMed ID: 7306321
[No Abstract] [Full Text] [Related]
37. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
[TBL] [Abstract][Full Text] [Related]
38. Effects of gonadotropin-releasing hormone agonist and clomiphene citrate on estrogen/progesterone-induced hyperprolactinemia in monkeys.
Groff TR; Olive DL; Riehl RM; Schenken RS
Fertil Steril; 1990 Feb; 53(2):346-50. PubMed ID: 2105248
[TBL] [Abstract][Full Text] [Related]
39. Acute changes in serum prolactin concentration have no effect on the secretion of progesterone, estradiol, or chorionic gonadotropin during early pregnancy.
Ranta T; Lehtovirta P; Stenman UH; Laatikainen T; Seppälä M
J Clin Endocrinol Metab; 1980 Sep; 51(3):544-7. PubMed ID: 7410533
[TBL] [Abstract][Full Text] [Related]
40. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
Parsanezhad ME; Alborzi S; Namavar Jahromi B
Arch Gynecol Obstet; 2004 Jan; 269(2):125-9. PubMed ID: 14648180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
